Vivos Therapeutics, Inc.VVOSNASDAQ
Loading
Stockholders Equity Over TimeStable
Percentile Rank67
3Y CAGR-32.2%
Studio
Year-over-Year Change

Net worth of the company (assets minus liabilities)

3Y CAGR
-32.2%/yr
Annual compound
Percentile
P67
Within normal range
vs 3Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
2024$7.95M+1835.3%
2023$411000.00-91.4%
2022$4.80M-81.2%
2021$25.54M+51.0%
2020$16.92M+674.8%
2019$-2.94M-161.0%
2018$4.83M-